Launch of Next-Generation Clinical Trial Data Platform
Rutland, MA, Oct. 5, 2017- A brand new clinical trial database and collaborative platform was launched on October 3, with the aim of being the leading source for every clinical trial data need. PrimaryEndpoints.com will serve a broad audience of biotech investors, clinical researchers, patients, and their advocates.
The revolutionary website offers several features previously unavailable, including:
· Crowdsourced trial predictions.
· Data visualizations of clinical trial data.
· Trial events and results.
· Personalized watchlists.
· Access to biotech gurus.
· Trial-centric discussions.
The site’s sleek modern design showcases all of the data available on clinicaltrials.gov, but with more accessibility and ease of use.
The site was founded by Tim Burr, a tech entrepreneur and biotech investor. After much time toiling on clinicaltrials.gov, he knew there was a problem that needed solving. Tim says, ''we wanted to create a platform to ease the tedium and information overload users face when analyzing and sorting through clinical trial data. Given its importance, clinical trial data needs to be ultra-accessible for anyone that needs it.''
What to expect:
People who need to access clinical trial information have been asking for a tool to simplify the monitoring and analyzation of clinical trial data, and Primary Endpoints wants to be the answer. With Primary Endpoints:
· Trial tracking is made easy with customized visual timelines.
· Trial outcomes are predicted by biotech experts.
· Customized notifications of trial updates ensure you are among the first to know.
· Communication with biotech experts and gurus is made easy.
· Join discussion boards and engage with clinical and investing experts.
Be among the first.
Don't miss the opportunity to be among the first to discover this next generation platform for clinical trial data. Visit http://www.primaryendpoints.com/ to experience Primary Endpoints for yourself.
Contact:
Product Manager: Bhavana Singh
Scopic Software 12 Carly Circle Rutland MA 01543 US Phone: (855) 717-5586 (toll free)
Email: marketing@primaryendpoints.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
